GLP-1 Protocols and Weight Management: What High-Performing Adults Should Know Before Starting
The patients who walk into our practice asking about semaglutide or tirzepatide are rarely the people you see in the manufacturer's marketing. They are 42-year-old founders, partners at law firms, surgeons, parents of three who run marathons on weekends. They are not sedentary. They eat reasonably well. And yet the last 15 to 30 pounds have become immovable, and the visceral fat has crept up despite their best efforts.
If that describes you, the conversation about GLP-1 medications is worth having properly, not as a quick prescription but as part of a deliberate protocol. Here is what I tell patients before we start.
What GLP-1s Actually Do
Glucagon-like peptide-1 is a hormone your gut releases after you eat. It signals the pancreas to release insulin, slows gastric emptying, and tells your brain you are satisfied. Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are engineered analogs that produce these signals at much higher doses and for much longer than your endogenous GLP-1 ever would. Tirzepatide adds GIP receptor activity, which appears to amplify the metabolic effect and, for many patients, produces greater changes in body composition.
The practical experience is straightforward. Food noise quiets down. Portions shrink without effort. The reward loop around alcohol, sugar, and late-night grazing loosens. Patients often describe it as feeling normal around food for the first time in years.
That is the upside. The protocol matters because the downsides, and the long-term success, depend almost entirely on how the medication is used.
Who Is Actually a Candidate
The FDA labels reference BMI thresholds (27 with a comorbidity, or 30 without). In a concierge setting, we look at more than BMI. A muscular 6'2" executive with a BMI of 28 and visceral adiposity on a DEXA scan is a very different patient from a sedentary person at the same BMI with sarcopenia. We want to see:
- A clear metabolic picture: fasting insulin, HbA1c, lipid panel including ApoB, hs-CRP, liver enzymes, and often a fasting GLP-1 or C-peptide depending on the case.
- Body composition data, ideally a DEXA scan, so we are tracking fat mass and lean mass separately rather than just weight on a scale.
- A thyroid panel and, where appropriate, sex hormone levels. Low testosterone in men and perimenopausal shifts in women both change how the body responds.
- An honest assessment of training, protein intake, sleep, and alcohol.
Contraindications matter. Personal or family history of medullary thyroid carcinoma or MEN2 takes GLP-1s off the table. History of pancreatitis, severe gastroparesis, or active gallbladder disease requires careful thought. Pregnancy or planning pregnancy in the near term is a hard stop.
The Protocol Is the Point
Most of the bad outcomes I see (rapid lean mass loss, the gaunt face, the rebound weight gain after stopping) come from a single error: treating the injection as the whole intervention. It is one component of four.
1. Dose titration, slowly
The standard escalation schedules are designed for tolerability across a large population. In our practice, we often move more slowly than the label, especially for high-performing patients who cannot afford a week of nausea before a board meeting or a trial. Starting low, holding doses longer, and titrating based on response usually produces a better experience and, frankly, better adherence. The lowest effective dose is the right dose.
2. Protein, deliberately
When appetite drops 40 percent, the temptation is to eat 40 percent less of everything. That is how patients lose muscle. The non-negotiable target is roughly 1.6 to 2.2 grams of protein per kilogram of goal body weight, distributed across the day. For most adults that means 30 to 50 grams per meal, every meal, even when you are not hungry. This is the single most important behavior change while on a GLP-1.
3. Resistance training
Two to four sessions a week of progressive resistance work. Not Pilates, not yoga, not zone 2 cardio (all of which have their place). Loaded compound movements. The goal is to give the body a reason to preserve, and ideally build, lean tissue while in a caloric deficit. Cardio is fine in addition, but it cannot substitute.
4. Monitoring
We re-check labs at 8 to 12 weeks and repeat body composition at 3 to 6 month intervals. If lean mass is dropping faster than fat mass, the protocol changes. If lipids or liver enzymes shift, we adjust. This is where concierge care earns its keep, because the medication is not a set-and-forget intervention.
Side Effects Worth Naming
Nausea, constipation, and reflux are common in the first weeks and usually settle. The more durable issues to watch for: sulfurous burping, a known quirk of tirzepatide in particular; gallbladder symptoms, especially with rapid weight reduction; and dehydration, which sneaks up when thirst signals also blunt. Hair shedding occurs in some patients around the 3 to 4 month mark and tends to resolve, though adequate protein and iron status help.
The "Ozempic face" everyone talks about is not a medication effect. It is a fat-loss effect. Lose facial fat at any age past 40 and the face looks older. The fix is not less medication; it is slower, smaller loss and more lean mass preservation.
The Exit Strategy Conversation
I bring this up at the first visit, not the last. What happens when you stop? The honest answer is that appetite returns and, without structural changes, much of the weight tends to come back. That does not mean GLP-1s are forever, but it does mean we plan deliberately. Some patients stay on a low maintenance dose long-term. Others taper off after reaching goals, having used the window to build training habits, fix sleep, address hormones, and rebuild their relationship with food. Both are legitimate. The wrong answer is not having a plan at all.
Compounded Versus Brand
With the FDA shortage list now resolved for semaglutide and tirzepatide, the compounding landscape has changed. We use FDA-approved manufactured products in nearly all cases. There are narrow circumstances where a documented clinical need justifies a compounded formulation, but the era of casual compounded GLP-1s from unverified sources is, and should be, ending. Source matters.
What to Ask Before You Start
- What is my baseline body composition, and how will we measure progress beyond the scale?
- What is my protein and training plan, specifically?
- How often will we re-evaluate labs and dose?
- What is the plan if I plateau, or if side effects become limiting?
- What does coming off the medication look like?
If the answers are vague, the protocol is vague. For adults who are accustomed to running complex systems at work, the standard for their own care should be at least as rigorous.
GLP-1 medications are among the most significant tools we have had in metabolic medicine in decades. Used well, inside a real protocol, they can change trajectories. Used carelessly, they produce smaller, weaker, frustrated patients who regain the weight. The difference is the medicine around the medicine.
If you are considering a GLP-1 protocol and want it built around your physiology, your labs, and your life, request a consultation with our team.
Related from Hew Health